A study that measured the expression of GLUT-1, GLUT-3, GLUT-6, and GLUT-10 in 150 gastric carcinomas by immunohistochemical (IHC) methods found that GLUT-1 was not associated with tumor stage or prognosis, but that GLUT-3 was associated with tumor stage (per the Union for International Cancer Control (UICC) guidelines) and survival [27]. Here, SLC2A1 is linked to neoplasm.